Stock BACT SYNCONA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Syncona Limited

Equities

BACT

GG00B8P59C08

Market Closed - London S.E.
Other stock markets
 11:35:02 2024-05-17 am EDT 		5-day change 1st Jan Change
107.6 GBX -2.36% Intraday chart for Syncona Limited -10.93% -12.80%
May. 17 Syncona notes Autolus's first quarter loss widens amid higher costs AN
May. 09 Syncona's Freeline gets positive results for Gaucher disease AN

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Syncona notes Autolus's first quarter loss widens amid higher costs
AN
Syncona's Freeline gets positive results for Gaucher disease
AN
Jefferies cuts AJ Bell; Deutsche likes ConvaTec
AN
Syncona agrees to sell stake in investee company for GBP7.4 million
AN
Syncona to Sell Stake in Portfolio Company to Century Therapeutics
MT
Syncona : Ascend acquires GMP manufacturing capacity in Alachua, Florida; Enters long-term partnership with Beacon Therapeutics for clinical and commercial AAV production
PU
BEST OF THE BROKERS
AQ
Syncona notes investee Achilles's annual loss narrows
AN
Syncona : Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA)
PU
Syncona : Autolus Therapeutics Announces Changes to its Board of Directors (1)
PU
Syncona portfolio company Autolus posts widened loss for 2023
AN
Syncona’s Takeover of Freeline Therapeutics Becomes Effective
MT
Freeline shareholders approve Syncona acquisition
AN
Freeline Therapeutics' Shareholders Approve Acquisition by Syncona
MT
Syncona portfolio strengthens in third quarter thanks to Autolus
AN
Syncona's Fiscal Q3 NAV Declines
MT
Tranche Update on Syncona Limited's Equity Buyback Plan announced on September 29, 2023.
CI
Syncona notes FDA acceptance of Autolus's BLA for obe-cel
AN
Syncona says Freeline trial for Gaucher disease treatment positive
AN
Syncona : Anaveon announces publication of ANV419 Phase I data in The Journal for ImmunoTherapy of Cancer
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BACT Stock
  4. News Syncona Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW